Effects of Acute Intake of Flavanols on Cerebral Oxygenation and Cognition in Young Male Adults

Sponsor
University of Birmingham (Other)
Overall Status
Completed
CT.gov ID
NCT04374409
Collaborator
University of Illinois at Urbana-Champaign (Other)
18
1
2
2.3
7.7

Study Details

Study Description

Brief Summary

The study evaluates the impact of one acute dose of cocoa flavanols on brain oxygenation during a hypercapnia challenge, as well as impact on cognitive performance in young healthy males. It further assesses the impact of flavanols on peripheral vascular function, as measured by brachial Flow-mediated dilation (FMD). All participants received a high-flavanol cocoa intervention (185.5 mg of flavanols (-)-epicatechin and (+)- catechin) and a low-flavanol cocoa intervention (< 4 mg of flavanols). It is hypothesized that the high-flavanol intervention increases cerebral oxygenation during hypercapnia and vascular function in comparison to the low-flavanol intervention.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: High-flavanol cocoa powder
  • Dietary Supplement: Low-flavanol cocoa powder
N/A

Detailed Description

Cocoa flavanols have been shown to be protective against vascular disease in humans, as evidenced by improvements in peripheral endothelial function (as measured by brachial Flow-mediated dilatation, FMD). There is also emerging evidence suggesting that flavanol-rich diets protect against cognitive aging, but mechanisms remain elusive. In this study the investigators suggest that such mechanisms might be associated with benefits within the brain vasculature. The aim of the present study was therefore to determine whether intake of flavanols enhances cerebral oxygenation in frontal cortical areas of the brain during a hypercapnia challenge (which is a well-established biomarker of vascular reactivity in the brain) to a greater extent than a low-flavanol intervention in young healthy adults.

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Basic Science
Official Title:
A Placebo-controlled, Randomized, Double-masked, Cross-over Acute Intervention Study Investigating the Effects of Flavanols on Cerebral Oxygenation and Cognition in Young Adults
Actual Study Start Date :
Oct 2, 2018
Actual Primary Completion Date :
Dec 12, 2018
Actual Study Completion Date :
Dec 12, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: High-flavanol Cocoa powder

Dietary supplement: single serving of a high-flavanol cocoa powder containing 150 mg of (-)-epicatechin and 35.5 mg of (+)-catechin

Dietary Supplement: High-flavanol cocoa powder
Non-alkalized fat-reduced cocoa powder (Natural Acticoa)

Active Comparator: Low-flavanol Cocoa powder

Dietary supplement: single serving of a low-flavanol cocoa powder intervention containing < 4 mg of (-)-epicatechin and (+)-catechin and matched as best as possible for macronutrients and micronutrients, such as caffeine and theobromine.

Dietary Supplement: Low-flavanol cocoa powder
Alkalized fat-reduced cocoa powder (10/12 DDP Royal Dutch)

Outcome Measures

Primary Outcome Measures

  1. Cortical Blood Oxygenation reactivity to hypercapnia using functional near-infrared spectroscopy (fNIRS) [Change from baseline to 2 hours]

    Cerebral oxygenated haemoglobin maximum levels in the frontal cortical regions of the brain during the 5% carbon-dioxide breathing challenge (average across minutes 3 and 4 of breathing challenge)

  2. Time to reach 90% of maximum cortical blood oxygenation during hypercapnia using functional near-infrared spectroscopy (fNIRS) [Change from baseline to 2 hours]

    Time to reach 90% of maximum oxygenated haemoglobin in the frontal cortical regions of the brain during the 5% carbon-dioxide breathing challenge

Secondary Outcome Measures

  1. Cortical Blood Deoxygenation reactivity to hypercapnia using functional near-infrared spectroscopy (fNIRS) [Change from baseline to 2 hours]

    Cerebral deoxygenated haemoglobin minimal levels in the frontal cortical regions of the brain during the 5% carbon-dioxide breathing challenge (average across minutes 3 and 4 of breathing challenge)

  2. Inverse Efficiency scores in a Modified version of the Stroop Task [2 hours post intervention]

    The modified Stroop included task blocks (designated as Colour match; Word match; Stroop and Double Stroop) of increasing difficulty so that performance could be compared between simple and more demanding tasks. Reaction time and accuracy of choice were recorded to estimate inverse efficiency scores (in seconds). Higher 'inverse efficiency scores' reflect worse performance on the task, whilst lower scores reflects better performance.

  3. Flow-mediated dilatation (FMD) of the brachial artery using ultrasound (expressed as % FMD: change in brachial diameter from baseline to peak dilation following 5 minutes of arterial occlusion).. [Change from baseline to 2 hours]

    FMD of the brachial artery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male

  • 18-45 years old

Exclusion Criteria:
  • smokers

  • hypertensive

  • with history of cerebrovascular, cardiovascular or respiratory disease

  • allergies or intolerances to ingredients present in cocoa powders

  • taking long-term medication (e.g., hyperlipidaemia)

  • on antibiotics for the previous 3 months before enrollment

  • suffering from blood-clotting disorders

  • known infections at the time of the study

  • on a weight-reducing regimen

Contacts and Locations

Locations

Site City State Country Postal Code
1 School of Sport, Exercise & Rehabilitation Sciences, University of Birmingham Birmingham United Kingdom B15 2TT

Sponsors and Collaborators

  • University of Birmingham
  • University of Illinois at Urbana-Champaign

Investigators

  • Principal Investigator: Catarina Rendeiro, PhD, University of Birmingham

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Catarina Rendeiro, Principal Investigator, University of Birmingham
ClinicalTrials.gov Identifier:
NCT04374409
Other Study ID Numbers:
  • ERN_17_1591
First Posted:
May 5, 2020
Last Update Posted:
May 11, 2020
Last Verified:
May 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Catarina Rendeiro, Principal Investigator, University of Birmingham

Study Results

No Results Posted as of May 11, 2020